LU91290I2 - Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr) - Google Patents

Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)

Info

Publication number
LU91290I2
LU91290I2 LU91290C LU91290C LU91290I2 LU 91290 I2 LU91290 I2 LU 91290I2 LU 91290 C LU91290 C LU 91290C LU 91290 C LU91290 C LU 91290C LU 91290 I2 LU91290 I2 LU 91290I2
Authority
LU
Luxembourg
Prior art keywords
salt
conveniar
cefovecine
optionally
including sodium
Prior art date
Application number
LU91290C
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909016189A external-priority patent/GB9016189D0/en
Priority claimed from GB919109540A external-priority patent/GB9109540D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of LU91290I2 publication Critical patent/LU91290I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
LU91290C 1990-07-24 2006-11-22 Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr) LU91290I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909016189A GB9016189D0 (en) 1990-07-24 1990-07-24 Novel compounds
GB919109540A GB9109540D0 (en) 1991-05-02 1991-05-02 Novel compounds
PCT/GB1991/001228 WO1992001696A1 (fr) 1990-07-24 1991-07-22 Cephalosporines et homologues, preparations et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
LU91290I2 true LU91290I2 (fr) 2007-01-22

Family

ID=26297372

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91290C LU91290I2 (fr) 1990-07-24 2006-11-22 Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)

Country Status (26)

Country Link
EP (2) EP0540609B1 (fr)
JP (2) JP2851428B2 (fr)
KR (1) KR100189075B1 (fr)
CN (2) CN1061046C (fr)
AP (1) AP832A (fr)
AT (1) ATE185567T1 (fr)
AU (1) AU648329B2 (fr)
CA (2) CA2359744C (fr)
CZ (1) CZ6493A3 (fr)
DE (2) DE69131714T2 (fr)
DK (1) DK0540609T3 (fr)
ES (1) ES2137162T3 (fr)
FI (1) FI930270A (fr)
GR (1) GR3031711T3 (fr)
HU (1) HUT63628A (fr)
IE (1) IE912569A1 (fr)
IL (1) IL98909A0 (fr)
LU (1) LU91290I2 (fr)
MX (1) MX9100317A (fr)
MY (1) MY106399A (fr)
NL (1) NL300249I1 (fr)
NO (1) NO930226L (fr)
NZ (1) NZ239061A (fr)
PT (1) PT98426A (fr)
WO (2) WO1992001695A1 (fr)
YU (1) YU129691A (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125645D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Novel compounds
EP0624160B1 (fr) * 1992-01-22 2001-10-31 Pfizer Inc. Derives de 2-isocephem et d'oxacephem, procedes de preparation, les intermediaires de ceux-ci et leur utilisation comme agents antibacteriens
GB9212609D0 (en) * 1992-06-13 1992-07-29 Smithkline Beecham Plc Novel compounds
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation
WO1998014421A1 (fr) * 1996-10-02 1998-04-09 Daiichi Pharmaceutical Co., Ltd. Procede d'esterification de composes carboxyliques
FR2776292B1 (fr) 1998-03-20 2004-09-10 Oncopharm Cephalotaxanes porteurs de chaine laterale et leur procede de synthese
GB0019124D0 (en) * 2000-08-03 2000-09-27 Pfizer Novel process
CN1243756C (zh) * 2000-12-04 2006-03-01 辉瑞产品公司 用于制备头孢菌素的方法和酯衍生物
JP2004520293A (ja) * 2000-12-04 2004-07-08 ファイザー・プロダクツ・インク セファロスポリン調製に有用なカップリング方法と中間体
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
KR100710555B1 (ko) 2001-12-04 2007-04-24 에스케이 주식회사 광학적으로 순수한 (ｒ)-폼 또는 (ｓ)-폼의테트라히드로퓨라닐 케톤의 제조방법
EP2794627B1 (fr) 2011-12-22 2018-09-26 Alios Biopharma, Inc. Nucléosides substitués, nucléotides substitués et analogues de ceux-ci
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
CA2871547C (fr) 2012-05-25 2021-05-25 Janssen R&D Ireland Nucleosides d'uracyl spirooxetane
KR102327888B1 (ko) 2012-12-21 2021-11-17 얀센 바이오파마, 인코퍼레이트. 치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
CN105254648B (zh) * 2015-11-13 2018-04-03 广东温氏大华农生物科技有限公司 一种头孢维星及其钠盐的合成方法
GB2575261B (en) 2018-07-02 2022-03-09 Norbrook Lab Ltd Intermediates in the synthesis of C3-substituted cephalosporins
TW202023625A (zh) 2018-08-23 2020-07-01 美商西雅圖遺傳學公司 抗tigit抗體
IL293592A (en) 2019-12-06 2022-08-01 Vertex Pharma Transduced tetrahydrofurans as sodium channel modulators
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
CN114213433B (zh) * 2020-06-08 2023-03-24 重庆医药高等专科学校 C-3位四氢呋喃取代的头孢菌素-铁载体耦合物的制备方法
KR20230170745A (ko) 2021-04-16 2023-12-19 길리애드 사이언시즈, 인코포레이티드 아미드를 사용한 카르바뉴클레오시드를 제조하는 방법
AR126073A1 (es) 2021-06-04 2023-09-06 Vertex Pharma N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2197573A1 (en) * 1972-09-07 1974-03-29 Roussel Uclaf 7-substd-phenylacetamido-cephalosporin derivs - - antibiotics active against streptococci and staphylococci
BE793448A (fr) * 1971-12-31 1973-06-28 Roussel Uclaf Procede de preparation de nouveaux derives des cephalosporines et produits obtenus
BE791161A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Procede pour la preparation d'analogues des cephalosporines
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
NL7305936A (fr) * 1972-05-05 1973-11-07
JPS5849382A (ja) * 1981-09-18 1983-03-23 Kyowa Hakko Kogyo Co Ltd β−ラクタム化合物
GB8821797D0 (en) * 1988-09-16 1988-10-19 Beecham Group Plc Novel compounds
ES2121745T3 (es) * 1989-03-30 1998-12-16 Pfizer Cefalosporinas y sus homologos, procedimiento para su preparacion y composiciones farmaceuticas.

Also Published As

Publication number Publication date
EP0540609B1 (fr) 1999-10-13
NL300249I2 (en) 2007-02-01
IL98909A0 (en) 1992-07-15
DK0540609T3 (da) 1999-12-27
AU8222491A (en) 1992-02-18
KR100189075B1 (ko) 1999-06-01
KR930701456A (ko) 1993-06-11
WO1992001696A1 (fr) 1992-02-06
AP9100305A0 (en) 1991-07-31
JPH05509305A (ja) 1993-12-22
WO1992001695A1 (fr) 1992-02-06
DE122006000065I1 (de) 2007-03-01
CA2359744A1 (fr) 1992-02-06
CN1111410C (zh) 2003-06-18
NZ239061A (en) 1993-11-25
HU9300177D0 (en) 1993-04-28
CA2087967C (fr) 2002-09-10
DE122006000065I2 (de) 2007-09-13
ES2137162T3 (es) 1999-12-16
ATE185567T1 (de) 1999-10-15
CA2359744C (fr) 2007-02-13
JPH05509089A (ja) 1993-12-16
HUT63628A (en) 1993-09-28
CN1060469A (zh) 1992-04-22
FI930270A0 (fi) 1993-01-22
CA2087967A1 (fr) 1992-01-25
CZ6493A3 (en) 1994-04-13
NO930226L (no) 1993-03-23
GR3031711T3 (en) 2000-02-29
DE69131714D1 (de) 1999-11-18
NL300249I1 (nl) 2007-02-01
YU129691A (sh) 1994-01-20
NO930226D0 (no) 1993-01-22
DE69131714T2 (de) 2000-02-24
MX9100317A (es) 1992-02-28
IE912569A1 (en) 1992-01-29
EP0540606A1 (fr) 1993-05-12
AU648329B2 (en) 1994-04-21
AP832A (en) 2000-05-03
MY106399A (en) 1995-05-30
JP2851428B2 (ja) 1999-01-27
FI930270A (fi) 1993-03-22
PT98426A (pt) 1992-05-29
CN1061046C (zh) 2001-01-24
EP0540609A1 (fr) 1993-05-12
CN1223859A (zh) 1999-07-28

Similar Documents

Publication Publication Date Title
LU91290I2 (fr) Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
LU88809I2 (fr) Lamivudine facultativement sous la forme d'un sel pharmaceutiquement acceptable
LU90468I2 (fr) Zanamivir facultativement sous la forme d'un sel ou d'un derive pharmaceutiquement acceptable
LU88842I2 (fr) Nebivolol optionnellement sous forme d'un sel ou d'un hydrate pharmaceutiquement acceptable en particulier hydroclorure de Nebivolol
LU91306I2 (fr) Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
LU92428I2 (fr) Bosutinib, éventuellement sous la forme d'un sel pharmaceutiquement acceptable
LU90593I2 (fr) Quetiapine facutativement sous forme d'un sel pharmaceutiquement acceptabe
LU91372I2 (fr) Retapamulin optionnellement sous forme d'un sel pharmaceutiquement acceptable (altargo)
LU91442I2 (fr) "Varénicline, optionnellement sous forme d'un sel pharmaceutiquement acceptable, y compris le sel tartrate"
YU58190A (en) Aminoacid's derivatives
NO912036L (no) Blekepreparat.
OA09323A (en) "Imadazo /4, 5-b/ quinolinyloxyalkanoic acid amides with enhanced water solubility".
LU88746I2 (fr) Valaciclovir facultativement sous la forme d'un sel pharmaceutiquement acceptable y compris le sel d'addition de l'acide chlorhydrique
EP0525106A4 (en) 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents
TR26214A (tr) Baryum veya stronsiyum sulfid'in lavgalanma artiklarinin hazirlanmasi.
ITTO910894A1 (it) "un procedimento per preparare dipeptidi".
FR2666235B1 (fr) Cuissard pour la pratique de l'escalade.
IT1236969B (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone.
IT1243851B (it) Cilindro di regolazione dell'inflessione.
OA09328A (en) "Heterocyclic compounds".
NO910607D0 (no) Fremgangsmaate for fremstilling av 3'-fluor-nukleosidanaloger.
IT212017Z2 (it) Cerotto, in particolare perl'impiego in corrispondenza di zone articolari.
ES512344A0 (es) "procedimiento para la preparacion continua, en una etapa, de granulados de cloruro de magnesio".
EP0415556A3 (en) Water soluble 1,2-dithio-3-thiones
MA21815A1 (fr) Capsule "s" .